Navigation Links
AcelRx Secures $40 Million Credit Facility with Hercules Technology Growth Capital
Date:12/19/2013

AcelRx has also announced positive top-line results for a Phase 2 trial for ARX-04, a product candidate for the treatment of moderate-to-severe acute pain in a medically supervised setting, funded through a grant from the U.S. Army Medical Research and Materiel Command. The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development. For additional information about AcelRx's clinical programs, please visit www.acelrx.com.

Forward Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements related to AcelRx Pharmaceuticals' financial viability, the sufficiency of funds to support its clinical and development program and operations, planned or anticipated future clinical development of AcelRx Pharmaceuticals' product candidates, the therapeutic and commercial potential of Zalviso and the anticipated timing, therapeutic and commercial potential of other AcelRx product candidates, and statements related to future events under the credit facility with Hercules, including its ability to access the third tranche funds under such facility. These forward-looking statements are based on AcelRx's current expectations and inherently involve significant risks and uncertainties. AcelRx's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: AcelRx's ability to receive regulatory approval for Zalviso; any delays or inability to obtain and maintain regulatory approval of its product candidates, including Zalviso, in the United States and Europe; its ability to attract funding partners or collaborators with development, regulatory and commercialization expertise; its ability to obt
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference
2. AcelRx Pharmaceuticals Adds New Board Member
3. Annual General Meeting Schedules, New Drug Applications, Positive Study Results, Conference Participations, and Secondary Offerings - Research Report on Mindray, AcelRx, Merrimack, ZELTIQ, and Clovis
4. AcelRx Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
5. AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results
6. AcelRx Pharmaceuticals to Hold Third Quarter 2013 Financial Results Conference Call and Webcast on November 5, 2013
7. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
8. AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
9. AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results
10. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
11. AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Switzerland , September 17, ... Debiopharm Group ™ , is proud to congratulate Biocartis ... instrument. Debiopharm Diagnostics is a long-time investor in ... Idylla ™ Biocartis, fully automated, real-time ... offer physicians fast and easy access to clinical ...
(Date:9/16/2014)... settembre 2014 Hologic, Inc. (NASDAQ: ... in Europa del Tomcat, un nuovo strumento preanalitico ... multifunzionale completamente automatizzata, progettata per semplificare la fase ... rischi di errore legati alla gestione manuale dei ... di Hologic riduce il carico di lavoro legato ...
(Date:9/16/2014)... 17. September 2014 Hologic, ... hat heute die Markteinführung des Tomcat, ... in Europa bekannt gegeben. Der Tomcat ... zur Vereinfachung der präanalytischen Probenverarbeitung. Dies ... fehlerbehaftete Arbeitsschritte bei der manuellen Aliquotierung ...
Breaking Medicine Technology:Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 3Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 3
... June 28, 2010 , , ... - Results of First Exposure of Type I Diabetes Patients to Oramed,s Oral,Insulin and of ... , , ... the 2010 Scientific Sessions of the,American Diabetes Association currently being held in Orlando, Florida ...
... Bayer HealthCare Pharmaceuticals today launched FactorTrack™, the first customizable mobile ... and interactive mobile application that helps make it easier to track ... , , ... and locations of bleeds.  It allows people with hemophilia A to ...
Cached Medicine Technology:Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 2Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 3Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment 2Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment 3
(Date:9/17/2014)... Harris, New York (PRWEB) September 17, 2014 ... join together with experienced coaches to complete a three ... annual Adventure Team Challenge New York . , ... New York’s Catskill Mountains, the 2014 Challenge includes five ... two coaches for each athlete with disabilities will provide ...
(Date:9/17/2014)... Skin management experts™ at FACE ... the first in the USA to introduce a new ... minimize the appearance of vertical chest lines and wrinkles. ... the first FDA-cleared ultrasound based facial procedure to non-invasively ... expanded their brand into tightening and smoothing the upper ...
(Date:9/17/2014)... As kids settle back into school ... mind for parents, teachers and coaches. Alexandra's Playground ... and an informative video, Pediatric Concussions: Early Detection ... teachers to detect, talk about and treat concussions ... orthopedic surgeon, I witness youth sports and playground ...
(Date:9/17/2014)... Colo. (PRWEB) September 17, 2014 In ... Sentinel University offers tips to health IT professionals for ... , A recent study by HIMSS shows demand for ... and a candidate’s skill set is the differentiating factor ... that of an IT professional that has clinical workflow ...
(Date:9/17/2014)... ICS Learning Group, Inc. won a coveted Brandon ... the Best Use of Games and Simulations for Learning. ... safety training module that ICS developed for one of ... approach that combined realistic 3D simulation with gamification, ICS ... a video game, including competition among trainees, to make ...
Breaking Medicine News(10 mins):Health News:World T.E.A.M. Sports’ Adventure Team Challenge New York Includes Disabled Athletes 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge New York Includes Disabled Athletes 3Health News:FACE Skincare Medical Wellness Debuts Ultherapy Décolletage Treatment 2Health News:Video Helps Kids and Adults Talk About Concussion Recognition and Treatment 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:ICS Learning Group Wins Gold in the 2014 Brandon Hall Excellence Competition for Best Use of Games and Simulations for Learning 2
... leukemia is curable with chemotherapy. The bad news is doctors ... the other 20 percent of patients. Now, new research finds ... that are resistant to drugs used to treat the disease. ... looked at the sensitivity of the cells to four different ...
... are significantly better at detecting cancers in women at high ... breast exams. ,The study involved around 1,900 women with ... included 358 women who also carried one of the genes ... disease. All of the women received a clinical breast exam ...
... one more good reason not to smoke. According to a ... of pregnancy increases the risk of having a baby with ... and England who were interviewed when their babies were about ... before and during pregnancy, including how many cigarettes she smoked ...
... Osteoporosis is a condition of low bone mass that ... painful disease. The disease is diagnosed by // bone ... increased researchers understanding of osteoporosis. ,Researchers looked at ... 2003.They reported that the number of physician visits for ...
... for low-fat salad dressing anymore. New research shows fats ... ,Researchers studied men and women between ages ... topped with salad dressing that contained zero, six or ... every 11 hours following each meal. ,Results showed ...
... patients with multiple sclerosis, according to a new study ... used to soothe nausea and to stimulate appetite.// Researchers ... with multiple sclerosis. ,24 patients with multiple sclerosis ... They were given up to 10 milligrams of dronabinol ...
Cached Medicine News:
... is a compact and quiet, yet ... 120 psi/8 bar, it provides more ... with noticeable noise reduction. A small, ... an enhanced ergonomic handpiece to produce ...
Relocatable frame has been designed specifically for fractionated stereotactic radiotherapy treatments. It provides a fast, non-invasive and reproducible fixation of the patient....
... is the most widely used ... flexibility, versatility and ease-of-use are ... Leksell Stereotactic System. The system ... principle and the basic components ...
Table-mounted, retraction for radiolucent anterior spine procedures. Fully-adjustable for any approach and any patient. Combine with our radiolucent blade kit for optimal visibility....
Medicine Products: